Bluejay Diagnostics, Inc., headquartered in Acton, MA, trades on Nasdaq and is seeking FDA approval for product submissions.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bluejay Diagnostics, Inc., headquartered in Acton, MA, trades on Nasdaq and is seeking FDA approval for product submissions.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
Acton
town in Massachusetts, United States
Nothing else this week.
Related events
- Aaron was listed on the Nasdaq stock exchange today.
- RedHill Biopharma Ltd., headquartered in Tel Aviv, is a company publicly traded on the Nasdaq exchange with its lead product approved by the FDA.
- Alnylam Pharmaceuticals listed its company stock on the Nasdaq exchange.
- BR Biopharma began trading on the Nasdaq exchange on November 10, 2026.
- BioNano Genomics traded on the Nasdaq stock exchange on July 9, 2026.